Clonidine Extended-Release Dosing and Titration in Adults
For clonidine extended-release in adults, start with 0.1 mg twice daily (morning and bedtime), then increase by 0.1 mg per day at weekly intervals as needed, with typical therapeutic doses ranging from 0.2-0.6 mg daily in divided doses. 1
Initial Dosing Strategy
- Start: 0.1 mg tablet twice daily (morning and bedtime)
- Elderly patients should receive a lower initial dose
- Consider taking the larger portion of the daily dose at bedtime to minimize transient side effects like dry mouth and drowsiness 1
Titration Schedule
- Increase by 0.1 mg per day at weekly intervals until desired blood pressure response is achieved
- The therapeutic range most commonly used is 0.2-0.6 mg per day in divided doses
- Maximum effective daily dose is 2.4 mg, though doses this high are rarely needed 1
Special Populations
Renal Impairment:
- Start with a lower initial dose
- Monitor patients carefully
- No supplemental dosing needed after hemodialysis (minimal drug removal during dialysis) 1
Critical Safety Considerations
Abrupt Discontinuation Risk:
- Never stop clonidine abruptly - this can cause rebound hypertension with norepinephrine surge 2
- This withdrawal syndrome is well-documented and potentially dangerous
- Continue clonidine up to 4 hours before surgery and resume as soon as possible postoperatively 1
Perioperative Management:
- Maintain therapy through the perioperative period due to withdrawal risk 2, 1
- Blood pressure should be carefully monitored during surgery
- Have additional BP control measures available if needed 1
Common Side Effects and Management
- Dry mouth and drowsiness are most common initially but often subside with continued therapy 3, 4
- Sedation may be increased by alcohol, barbiturates, or other sedating drugs 1
- Patients should be cautioned about driving or operating machinery
- Contact lens wearers may experience eye dryness 1
Drug Interactions to Monitor
- Tricyclic antidepressants may reduce clonidine's hypotensive effect, requiring dose increase 1
- Monitor heart rate when used with agents affecting sinus node function (digitalis, calcium channel blockers, beta-blockers) - sinus bradycardia requiring pacemaker insertion has been reported with diltiazem or verapamil 1
- Neuroleptics may induce or exacerbate orthostatic hypotension 1
Evidence Quality Note
The sustained-release formulations (250-500 mcg/day) have shown equivalent blood pressure control to standard tablets with fewer side effects and better patient preference in crossover studies 3, 4. However, the FDA labeling provides the definitive dosing guidance for immediate-release formulations, which should be followed for standard practice.